Naseem Amin

Insider Reports History

Location
Hampton, NJ
Signature
/s/ Robert E. Puopolo, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naseem Amin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bellerophon Therapeutics, Inc. Director Common Stock 291,865 $30,296 $0.1038 07 Jun 2023 Direct
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 0 $0 $21.00 12 Feb 2026 Direct
AVADEL PHARMACEUTICALS PLC Director Stock Option (Right to Buy) 0 12 Feb 2026 Direct

Insider Reports Filed by Naseem Amin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVDL AVADEL PHARMACEUTICALS PLC 12 Feb 2026 4 -$462,000 4 Director 12 Feb 2026, 17:31
AVDL AVADEL PHARMACEUTICALS PLC 29 Jul 2025 2 $0 4 Director 31 Jul 2025, 16:06
AVDL AVADEL PHARMACEUTICALS PLC 30 Jul 2024 2 $0 4 Director 01 Aug 2024, 16:35
AVDL AVADEL PHARMACEUTICALS PLC 17 May 2024 1 $0 4 Director 21 May 2024, 17:29
AVDL AVADEL PHARMACEUTICALS PLC 17 May 2024 0 $0 3 Director 21 May 2024, 17:27
/report/000110465923069913-amin-naseem-2023-06-07 Bellerophon Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:12
/report/000141588923002555-amin-naseem-2023-02-10 Bellerophon Therapeutics, Inc. 10 Feb 2023 1 $0 4 Director 14 Feb 2023, 18:32
/report/000141588922000186-amin-naseem-2021-12-31 Bellerophon Therapeutics, Inc. 31 Dec 2021 2 +$26,880 4 Director 04 Jan 2022, 15:10